Cutaneous Infiltration due to Waldenström Macroglobulinemia. 2018

S Oscoz-Jaime, and A D Agulló-Pérez, and C Llanos-Chavarri, and J I Yanguas-Bayona
Servicio de Dermatología, Complejo Hospitalario de Navarra, Pamplona (Navarra), España. Electronic address: saioaoscoz@gmail.com.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008258 Waldenstrom Macroglobulinemia A lymphoproliferative disorder characterized by pleomorphic B-LYMPHOCYTES including PLASMA CELLS, with increased levels of monoclonal serum IMMUNOGLOBULIN M. There is lymphoplasmacytic cells infiltration into bone marrow and often other tissues, also known as lymphoplasmacytic lymphoma. Clinical features include ANEMIA; HEMORRHAGES; and hyperviscosity. Lymphoma, Lymphoplasmacytoid,Macroglobulinemia,Familial Waldenstrom's Macroglobulinaemia,Lymphoma, Lymphocytic, Plasmacytoid,Primary Macroglobulinemia,Waldenstrom's Macroglobulinaemia,Waldenstrom's Macroglobulinemia,Familial Waldenstrom Macroglobulinaemia,Familial Waldenstroms Macroglobulinaemia,Lymphomas, Lymphoplasmacytoid,Lymphoplasmacytoid Lymphoma,Lymphoplasmacytoid Lymphomas,Macroglobulinaemia, Familial Waldenstrom's,Macroglobulinaemia, Waldenstrom's,Macroglobulinemia, Primary,Macroglobulinemia, Waldenstrom,Macroglobulinemia, Waldenstrom's,Waldenstrom Macroglobulinaemia,Waldenstrom's Macroglobulinaemia, Familial,Waldenstroms Macroglobulinaemia,Waldenstroms Macroglobulinemia
D008297 Male Males
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D010950 Plasma Cells Specialized forms of antibody-producing B-LYMPHOCYTES. They synthesize and secrete immunoglobulin. They are found only in lymphoid organs and at sites of immune responses and normally do not circulate in the blood or lymph. (Rosen et al., Dictionary of Immunology, 1989, p169 & Abbas et al., Cellular and Molecular Immunology, 2d ed, p20) Plasmacytes,Cell, Plasma,Cells, Plasma,Plasma Cell,Plasmacyte
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069283 Rituximab A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS. CD20 Antibody, Rituximab,GP2013,IDEC-C2B8,IDEC-C2B8 Antibody,Mabthera,Rituxan,IDEC C2B8,IDEC C2B8 Antibody,Rituximab CD20 Antibody
D000069461 Bendamustine Hydrochloride A nitrogen mustard compound that functions as an ALKYLATING ANTINEOPLASTIC AGENT and is used in the treatment of CHRONIC LYMPHOCYTIC LEUKEMIA and NON-HODGKIN'S LYMPHOMA. Bendamustin,Bendamustine,Cytostasan,IMET 3393,Ribomustin,Treanda,Zimet 3393,Hydrochloride, Bendamustine
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy

Related Publications

S Oscoz-Jaime, and A D Agulló-Pérez, and C Llanos-Chavarri, and J I Yanguas-Bayona
September 2006, Leukemia research,
S Oscoz-Jaime, and A D Agulló-Pérez, and C Llanos-Chavarri, and J I Yanguas-Bayona
January 2023, [Rinsho ketsueki] The Japanese journal of clinical hematology,
S Oscoz-Jaime, and A D Agulló-Pérez, and C Llanos-Chavarri, and J I Yanguas-Bayona
August 2020, JAAD case reports,
S Oscoz-Jaime, and A D Agulló-Pérez, and C Llanos-Chavarri, and J I Yanguas-Bayona
January 1981, Annales de dermatologie et de venereologie,
S Oscoz-Jaime, and A D Agulló-Pérez, and C Llanos-Chavarri, and J I Yanguas-Bayona
July 2016, Nihon rinsho. Japanese journal of clinical medicine,
S Oscoz-Jaime, and A D Agulló-Pérez, and C Llanos-Chavarri, and J I Yanguas-Bayona
April 2012, Hematology (Amsterdam, Netherlands),
S Oscoz-Jaime, and A D Agulló-Pérez, and C Llanos-Chavarri, and J I Yanguas-Bayona
October 2014, Hematology/oncology clinics of North America,
S Oscoz-Jaime, and A D Agulló-Pérez, and C Llanos-Chavarri, and J I Yanguas-Bayona
December 2013, Orvosi hetilap,
S Oscoz-Jaime, and A D Agulló-Pérez, and C Llanos-Chavarri, and J I Yanguas-Bayona
January 2021, Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti,
S Oscoz-Jaime, and A D Agulló-Pérez, and C Llanos-Chavarri, and J I Yanguas-Bayona
January 1957, Bulletins et memoires de la Societe medicale des hopitaux de Paris,
Copied contents to your clipboard!